INTRODUCTION:
Radiation Oncology is a branch of Oncology which concerns with the treatment of malignant and benign tumours using high energy ionising radiations. The treatment process is called Radiotherapy. Almost two-third of all cancer patients require to be treated with Radiotherapy.
The Radiation Oncology services was inaugurated by Honourable Chairman – KLE SOCIETY, Dr Prabhakar Kore on 23rd of April 2023, at the new KLE Cancer Hospital.
KLE Cancer Hospital is equipped with 2 high-end Linear Accelerators (LINACs)– Varian Halcyon Elite and Varian TrueBeam, capable of delivering Intensity modulated Radiotherapy (IMRT) with image guidance (IGRT), Rapid Arc (VMAT), Hyper Arc, Stereotactic Body Radiotherapy (SBRT) and Radiosurgery (SRS) – translating to quick and accurate treatment delivery in all the cancer sites with minimal side effects. The treatment planning process involves virtual simulation process with Siemens CT simulator which helps in imaging the tumour with 3D and 4D reconstruction. The latest and advanced version of Eclipse treatment planning system uses artificial intelligence for the treatment planning and evaluation.
The Saginova Brachytherapy unit houses High Dose Rate (HDR) Cobalt-60 radioactive source which is used to treat tumours with greater focus and coverage as the radiation is delivered close to the tumours. This unit is compatible with intra-cavitary, interstitial, intra-luminal and surface mould brachytherapy.
The quality assurance of the proposed treatment, evaluation during and after treatment and all the machine related parameters are impeccably tested daily, assuring safe and effective treatment.
Lead by Dr Imtiaz Ahmed (In-charge Head), with a team of experienced Radiation Oncologists trained at India’s premier Medical Institutes, along with experienced team of Physicists and Technologists, the Department of Radiation Oncology is envisioned to be one of its kind in the whole of North Karnataka, Goa, and Maharashtra, with the sole aim of providing quality cancer care to the patients.